Stellenbosch University and biotech company tackle COVID-19 together

(Stellenbosch University) In the hope of contributing towards assisting treatment of patients with severe effects related to the condition, the collaboration will see the partners further develop SynSurf ® , a synthetic pharmaceutical to be tested as a supportive agent for the treatment of Acute/Adult Respiratory Distress Syndrome (ARDS). Based on the latest research, ARDS has been cited as one of the major reasons that COVID-19 patients become critically ill and/or die.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news